<p>ELISA = Enzyme-Linked Immunosorbent Assay; PCR = Polymerase Chain Reaction; S1 = survey 1; S2 = survey 2.</p
<p>IgM: Top 20 <i>P</i>. <i>falciparum</i> antigens by magnitude recognized by patient sera.</p
<p>Prevalence (%) of <i>Plasmodium</i>/<i>Haemoproteus</i> in the three different areas studied by P...
<p>Red squares indicate the <i>P. falciparum</i> infection/<i>P. vivax</i> infection (PF/PV) ratio; ...
Comparison of incidence rate ratios of P. falciparum infections detected by ultrasensitive quantitat...
<p>Seroprevalence to <i>P. falciparum</i> antigens MSP-1<sub>42</sub> and AMA-1 by age category with...
<p>Total height of each bar (blue + red) represents the PCR prevalence. Countries where data were co...
<p>* Not available data. Technical problems in the performance of the molecular analyses (PCR) for <...
The global burden of malaria has been substantially reduced over the past two decades. Future effort...
BACKGROUND: Large-scale mapping of Plasmodium falciparum infection prevalence relies on opportunisti...
<p>Prevalence of <i>P</i>. <i>falciparum</i> csp haplotype based on NANP and NVDP repeats and their ...
<p>Distribution of <i>P</i>. <i>falciparum</i> infected and exposed individuals by study site (A, B,...
<p>A) <i>P</i>.<i>vivax and P</i>.<i>falciparum</i> prevalence by LM (white circles) or qPCR (black ...
a<p>Positive cutoff = mean of 20 <i>P. falciparum</i> unexposed controls +3 standard deviations.</p>...
<p> <b>Notes:</b></p>1<p>Seropositive (number of seropositive individuals) and perce...
<p>Summary of Khartoum <i>P. falciparum</i> prevalence data from 256 surveys in 203 locations (some ...
<p>IgM: Top 20 <i>P</i>. <i>falciparum</i> antigens by magnitude recognized by patient sera.</p
<p>Prevalence (%) of <i>Plasmodium</i>/<i>Haemoproteus</i> in the three different areas studied by P...
<p>Red squares indicate the <i>P. falciparum</i> infection/<i>P. vivax</i> infection (PF/PV) ratio; ...
Comparison of incidence rate ratios of P. falciparum infections detected by ultrasensitive quantitat...
<p>Seroprevalence to <i>P. falciparum</i> antigens MSP-1<sub>42</sub> and AMA-1 by age category with...
<p>Total height of each bar (blue + red) represents the PCR prevalence. Countries where data were co...
<p>* Not available data. Technical problems in the performance of the molecular analyses (PCR) for <...
The global burden of malaria has been substantially reduced over the past two decades. Future effort...
BACKGROUND: Large-scale mapping of Plasmodium falciparum infection prevalence relies on opportunisti...
<p>Prevalence of <i>P</i>. <i>falciparum</i> csp haplotype based on NANP and NVDP repeats and their ...
<p>Distribution of <i>P</i>. <i>falciparum</i> infected and exposed individuals by study site (A, B,...
<p>A) <i>P</i>.<i>vivax and P</i>.<i>falciparum</i> prevalence by LM (white circles) or qPCR (black ...
a<p>Positive cutoff = mean of 20 <i>P. falciparum</i> unexposed controls +3 standard deviations.</p>...
<p> <b>Notes:</b></p>1<p>Seropositive (number of seropositive individuals) and perce...
<p>Summary of Khartoum <i>P. falciparum</i> prevalence data from 256 surveys in 203 locations (some ...
<p>IgM: Top 20 <i>P</i>. <i>falciparum</i> antigens by magnitude recognized by patient sera.</p
<p>Prevalence (%) of <i>Plasmodium</i>/<i>Haemoproteus</i> in the three different areas studied by P...
<p>Red squares indicate the <i>P. falciparum</i> infection/<i>P. vivax</i> infection (PF/PV) ratio; ...